1 study found for:    NCT00324987
Show Display Options
Rank Status Study
1 Active, not recruiting Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumor
Interventions: Drug: imatinib mesylate;   Biological: bevacizumab;   Other: laboratory biomarker analysis;   Other: pharmacological study

Indicates status has not been verified in more than two years